Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
Bontha Babu, Scientist-G (Director Grade Scientist) and Head at Indian Council of Medical Research, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Quality of Life Research, adding:
“Pleased to share our latest publication in Quality of Life Research!
‘Health-related quality of life among adults with sickle cell disease in India: a multicentric longitudinal study of associated factors and calendar-season differences.’
In this multicentric longitudinal study, we assessed health-related quality of life (HRQoL) among 120 adults with sickle cell disease (SCD) and 120 matched non-SCD participants across four predominantly tribal districts in India, over four seasons.
Our findings revealed that adults with SCD had significantly poorer HRQoL across all eight SF-36 domains. Higher educational attainment was associated with better physical and mental HRQoL, while greater pain intensity and recent hospitalisation were associated with poorer physical HRQoL.
Seasonal differences were observed in selected domains, although no consistent pattern emerged across seasons.
The key message is that SCD care must go beyond managing clinical complications. Integrating routine HRQoL assessment, strengthening pain management and providing post-hospitalisation support could contribute to more comprehensive, patient-centred care, particularly in underserved communities.
Grateful to all my co-authors, collaborators and study participants for their valuable contributions.”
Title: Health-related quality of life among adults with sickle cell disease in India: a multicentric longitudinal study of associated factors and calendar-season differences
Authors: Madhusmita Bal, Arundhuti Das, Parikipandla Sridevi, Deepa Bhat, Shaily B. Surti, Jatin Sarmah, Yogita Sharma, Manoranjan Ranjit, Rabindra K. Jena, Bontha V. Babu

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research